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The article ‘Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moon-
lighting function’ by Niehaus et al. published in this issue illustrates a number of the problems
that still arise when attempting to translate genotypes to phenotypes, such as for interpreting
mutant phenotypes or building genome-scale metabolic models. In this case, the mutation
concerned appears to map to an enzyme in one of the little-known but essential metabo-
lite repair pathways that have been discovered in recent years. However, the bioinformatic
and experimental evidence presented suggests that the annotated enzyme activity of the
mutated gene product, whilst correct, accounts neither for the phenotype nor for the chro-
mosomal and transcriptional associations of the gene. The bioinformatic and metabolomic
evidence presented points to an additional but important role for the gene product in pyri-
doxal phosphate homoeostasis, thus adding the enzyme to the expanding list of those with
a ‘moonlighting function’.
The article ‘Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting
function’ by Niehaus et al. [1] in this issue could appear from its title to be just a footnote about a
little-known metabolic pathway, but in fact it raises issues that impact on a number of very active ar-
eas of contemporary research. The question they raise is whether the enzyme NAD(P)HX epimerase (EC
5.1.99.6) has a second function outside the NAD(P)H repair pathway to which it is said to belong, related
to pyridoxal 5-phosphate metabolism. In this case, the human metabolic disorder associated with muta-
tion of the gene for the epimerase [2] might have other causes than accumulation of NAD(P)HX. Why
should this investigation into a specific gene–protein–reaction association have implications outside the
areas of metabolism directly involved? There are a number of reasons that interact to cause this.
One is that the accuracy of gene–protein–function assignments is central to the interpretation of organ-
isms’ genome sequences and relating them to biological properties. The gene–protein–enzyme relation-
ship was established by Tatum and Beadle [3] as the basis for the genetic encoding of metabolic pathways,
so once complete genome sequences became available, there was the development of the technique of
genome-scale metabolic modelling [4]. This takes the annotation of the genome sequence, identifies the
metabolic enzymes and generates a list of the reactions they catalyse, which can then be used to compute
metabolic properties, including the prediction of phenotypes of metabolic mutants. As more and more
organisms are sequenced, this enables metabolic models to be built of organisms that have not been the
subject of much biochemical investigation, so many of the gene–enzyme associations involved are indi-
rect and derived by bioinformatic techniques such as sequence homology with known examples, and the
enzyme–reaction associations from databases collating research literature. Though the reliability of these
chains of inferences cannot be certain, there are other sources of uncertainty that need to be considered.
The paper alludes to one of these other sources of uncertainty: the completeness of our knowledge of
metabolism, even in biochemically well-studied organisms. All genome sequences contain coding regions
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that cannot be assigned a function by bioinformaticmethods, and it is likely that there aremetabolic enzymes amongst
these unannotated genes, especially as genome-scale metabolic models frequently have network gaps, where a reac-
tion needed to ensure necessary connectedness of the network cannot be linked to a gene. However, in recent years
there has been increasing awareness of newmetabolic reactions associatedwithmetabolite damage repair [5]. The re-
pair pathways dealwith compounds that arederived frommetabolites, either through spontaneous chemical reactions
(such as oxidation or hydrolysis) or throughminor side reactions of enzymes with them because of structural similar-
ities with natural substrates.Where these derivedmetabolites are not participants in normal centralmetabolism, they
will accumulate unless either converted to a metabolite that is or excreted. This is the case in the paper by Niehaus et
al. [1]: NAD(P)HX is formed spontaneously by the hydration of NADH and NADP, and the repair pathway involves
returning it to its original state [6].However, though the dehydratase component of the pathway is known to be nec-
essary, it is uncertain whether the epimerase activity, which interconverts the R and S epimers (the substrate of the
dehydratase), is needed given that the epimerization reaction occurs spontaneously. Indeed, part of the evidence in
the paper is that inactivating the epimerase in Escherichia coli with a point mutation did not lead to abnormally high
NAD(P)HX levels.
Another confounding issue in the mapping of genome sequence to a metabolic phenotype is the main topic of
the paper: enzyme moonlighting, that is, an enzyme participating in another process within a cell that is distinct
from its catalytic activity and often not even a direct metabolic function. There are now several hundred known
examples [7]. The existence of moonlighting complicates the comparison with experimental data of gene essentiality
computed from genome-scale metabolic models since the enzyme activity encoded by the gene may not be necessary
for viability and functioning of the metabolic network, but the gene will be essential if the moonlighting function
is. As in this paper, it also obscures whether the functional lesion in the case of a defective phenotype is associated
with the metabolic process or the moonlighting function [8]. Niehaus et al. [1] demonstrate that, in the case of the
epimerase, it is likely that it is themoonlighting function since the pointmutation inE. coli didnot have a significantly
defective phenotype whereas deletion of the protein did. The nature of the defective phenotype pointed to a role for
the epimerase protein in pyridoxal-associated metabolism, though whether that was via a different enzyme activity
or some other process was not established.
In conclusion, Niehaus et al. [1] illustrate some of the consequences of the gaps in our knowledge of metabolism
and enzymology for the exploitation of genome sequence information and for connecting genotype to phenotype.
Though the rise of high-throughput techniques for the study of nucleic acids has eclipsed research inmetabolism and
enzymology, it is clear that continued progress the latter is still needed to allow full exploitation of the information
in genome sequences. Consequences of these knowledge gaps have also been pointed out for synthetic biology and
metabolic engineering developments [9] since the introduction of designed, novel enzymes and pathways into cells
could create new damage pathways and metabolites in both the native and engineered metabolism that would need
to be countered to achieve the desired outcomes.
Competing Interests
The author declares that there are no competing interests associated with the manuscript.
References
1 Niehaus, T.D., Elbadawi-Sidhu, M., Huang, L., Prunetti, L., Gregory, III, J.F., de Cre´cy-Lagard, V. et al. (2018) Evidence that the metabolite repair enzyme
NAD(P)HX epimerase has a moonlighting function. Biosci. Rep. 38, BSR20180223, https://doi.org/doi:10.1042/BSR20180223
2 Kremer, L.S., Danhauser, K., Herebian, D., Ramadza, D.P., Piekutowska-Abramczuk, D., Seibt, A. et al. (2016) NAXE mutations disrupt the cellular
NAD(P)HX repair system and cause a lethal neurometabolic disorder of early childhood. Amer. J. Human Genet. 99, 894–902,
https://doi.org/10.1016/j.ajhg.2016.07.018
3 Tatum, E.L. and Beadle, G.W. (1945) Biochemical genetics of Neurospora. Ann. Mo. Bot. Gard 32, 125–129, https://doi.org/10.2307/2394252
4 Edwards, J.S. and Palsson, B.O. (2000) The Escherichia coli MG1655 in silico Metabolic Genotype: Its deﬁnition, characteristics and capabilities. Proc.
Natl. Acad. Sci. U.S.A. 97, 5528–5533, https://doi.org/10.1073/pnas.97.10.5528
5 Linster, C.L., Van Schaftingen, E. and Hanson, A.D. (2013) Metabolite damage and its repair or pre-emption. Nat. Chem. Biol. 9, 72–80,
https://doi.org/10.1038/nchembio.1141
6 Marbaix, A.Y., Tyteca, D., Niehaus, T.D., Hanson, A.D., Linster, C.L. and Van Schaftingen, E. (2014) Occurrence and subcellular distribution of the
NAD(P)HX repair system in mammals. Biochem. J. 460, 49–58, https://doi.org/10.1042/BJ20131482
7 Chen, C., Zabad, S., Liu, H., Wang, W. and Jeffery, C. (2018) MoonProt 2.0: an expansion and update of the moonlighting proteins database. Nucleic
Acids Res. 46, D640–D644, https://doi.org/10.1093/nar/gkx1043
8 Van Schaftingen, E., Veiga-da Cunha, M. and Linster, C.L. (2015) Enzyme complexity in intermediary metabolism. J. Inherited Metab. Dis. 38, 721–727,
https://doi.org/10.1007/s10545-015-9821-0
9 Sun, J., Jeffryes, J.G., Henry, C.S., Bruner, S.D. and Hanson, A.D. (2017) Metabolite damage and repair in metabolic engineering design. Metabol. Eng.
44, 150–159, https://doi.org/10.1016/j.ymben.2017.10.006
2 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
